Journal article
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- Abstract:
-
Background
In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation.Methods
This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. Those trial participants with hypoxia (oxygen saturation <92% on ... Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Lancet Journal website
- Volume:
- 397
- Issue:
- 10285
- Pages:
- 1637-1645
- Publication date:
- 2021-04-29
- Acceptance date:
- 2021-03-12
- DOI:
- EISSN:
-
1474-547X
- ISSN:
-
0140-6736
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
1167227
- Local pid:
- pubs:1167227
- Deposit date:
- 2021-03-12
Terms of use
- Copyright holder:
- Horby et al.
- Copyright date:
- 2021
- Rights statement:
- © 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under a Creative Commons license.
- Licence:
- CC Attribution (CC BY)
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record